Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis

Lysophosphatidylserine (lysoPS) is known to regulate immune cell functions. Phospholipase A1 member A (PLA1A) can generate this bioactive lipid through hydrolysis of sn-1 fatty acids on phosphatidylserine (PS). PLA1A has been associated with cancer metastasis, asthma, as well as acute coronary syndr...

Full description

Bibliographic Details
Main Authors: Yang Zhao, Stephan Hasse, Myriam Vaillancourt, Chenqi Zhao, Lynn Davis, Eric Boilard, Paul Fortin, John Di Battista, Patrice E. Poubelle, Sylvain G. Bourgoin
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/12685
_version_ 1797507800421629952
author Yang Zhao
Stephan Hasse
Myriam Vaillancourt
Chenqi Zhao
Lynn Davis
Eric Boilard
Paul Fortin
John Di Battista
Patrice E. Poubelle
Sylvain G. Bourgoin
author_facet Yang Zhao
Stephan Hasse
Myriam Vaillancourt
Chenqi Zhao
Lynn Davis
Eric Boilard
Paul Fortin
John Di Battista
Patrice E. Poubelle
Sylvain G. Bourgoin
author_sort Yang Zhao
collection DOAJ
description Lysophosphatidylserine (lysoPS) is known to regulate immune cell functions. Phospholipase A1 member A (PLA1A) can generate this bioactive lipid through hydrolysis of sn-1 fatty acids on phosphatidylserine (PS). PLA1A has been associated with cancer metastasis, asthma, as well as acute coronary syndrome. However, the functions of PLA1A in the development of systemic autoimmune rheumatic diseases remain elusive. To investigate the possible implication of PLA1A during rheumatic diseases, we monitored PLA1A in synovial fluids from patients with rheumatoid arthritis and plasma of early-diagnosed arthritis (EA) patients and clinically stable systemic lupus erythematosus (SLE) patients. We used human primary fibroblast-like synoviocytes (FLSs) to evaluate the PLA1A-induced biological responses. Our results highlighted that the plasma concentrations of PLA1A in EA and SLE patients were elevated compared to healthy donors. High concentrations of PLA1A were also detected in synovial fluids from rheumatoid arthritis patients compared to those from osteoarthritis (OA) and gout patients. The origin of PLA1A in FLSs and the arthritic joints remained unknown, as healthy human primary FLSs does not express the PLA1A transcript. Besides, the addition of recombinant PLA1A stimulated cultured human primary FLSs to secrete IL-8. Preincubation with heparin, autotaxin (ATX) inhibitor HA130 or lysophosphatidic acid (LPA) receptor antagonist Ki16425 reduced PLA1A-induced-secretion of IL-8. Our data suggested that FLS-associated PLA1A cleaves membrane-exposed PS into lysoPS, which is subsequently converted to LPA by ATX. Since primary FLSs do not express any lysoPS receptors, the data suggested PLA1A-mediated pro-inflammatory responses through the ATX-LPA receptor signaling axis.
first_indexed 2024-03-10T04:53:35Z
format Article
id doaj.art-b65a1cf4393f452dbf137037cd027a6b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:53:35Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b65a1cf4393f452dbf137037cd027a6b2023-11-23T02:26:21ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-11-0122231268510.3390/ijms222312685Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor AxisYang Zhao0Stephan Hasse1Myriam Vaillancourt2Chenqi Zhao3Lynn Davis4Eric Boilard5Paul Fortin6John Di Battista7Patrice E. Poubelle8Sylvain G. Bourgoin9Centre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaDepartment of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC H3G 2M1, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaCentre de Recherche du CHU de Québec, Université Laval, Québec, QC G1V 4G2, CanadaLysophosphatidylserine (lysoPS) is known to regulate immune cell functions. Phospholipase A1 member A (PLA1A) can generate this bioactive lipid through hydrolysis of sn-1 fatty acids on phosphatidylserine (PS). PLA1A has been associated with cancer metastasis, asthma, as well as acute coronary syndrome. However, the functions of PLA1A in the development of systemic autoimmune rheumatic diseases remain elusive. To investigate the possible implication of PLA1A during rheumatic diseases, we monitored PLA1A in synovial fluids from patients with rheumatoid arthritis and plasma of early-diagnosed arthritis (EA) patients and clinically stable systemic lupus erythematosus (SLE) patients. We used human primary fibroblast-like synoviocytes (FLSs) to evaluate the PLA1A-induced biological responses. Our results highlighted that the plasma concentrations of PLA1A in EA and SLE patients were elevated compared to healthy donors. High concentrations of PLA1A were also detected in synovial fluids from rheumatoid arthritis patients compared to those from osteoarthritis (OA) and gout patients. The origin of PLA1A in FLSs and the arthritic joints remained unknown, as healthy human primary FLSs does not express the PLA1A transcript. Besides, the addition of recombinant PLA1A stimulated cultured human primary FLSs to secrete IL-8. Preincubation with heparin, autotaxin (ATX) inhibitor HA130 or lysophosphatidic acid (LPA) receptor antagonist Ki16425 reduced PLA1A-induced-secretion of IL-8. Our data suggested that FLS-associated PLA1A cleaves membrane-exposed PS into lysoPS, which is subsequently converted to LPA by ATX. Since primary FLSs do not express any lysoPS receptors, the data suggested PLA1A-mediated pro-inflammatory responses through the ATX-LPA receptor signaling axis.https://www.mdpi.com/1422-0067/22/23/12685phosphatidylserine-specific phospholipase A1lyso-phospholipidlysophosphatidic acidlyso-phosphatidylserineautotaxinchemokines
spellingShingle Yang Zhao
Stephan Hasse
Myriam Vaillancourt
Chenqi Zhao
Lynn Davis
Eric Boilard
Paul Fortin
John Di Battista
Patrice E. Poubelle
Sylvain G. Bourgoin
Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
International Journal of Molecular Sciences
phosphatidylserine-specific phospholipase A1
lyso-phospholipid
lysophosphatidic acid
lyso-phosphatidylserine
autotaxin
chemokines
title Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
title_full Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
title_fullStr Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
title_full_unstemmed Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
title_short Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
title_sort phospholipase a1 member a activates fibroblast like synoviocytes through the autotaxin lysophosphatidic acid receptor axis
topic phosphatidylserine-specific phospholipase A1
lyso-phospholipid
lysophosphatidic acid
lyso-phosphatidylserine
autotaxin
chemokines
url https://www.mdpi.com/1422-0067/22/23/12685
work_keys_str_mv AT yangzhao phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT stephanhasse phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT myriamvaillancourt phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT chenqizhao phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT lynndavis phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT ericboilard phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT paulfortin phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT johndibattista phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT patriceepoubelle phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis
AT sylvaingbourgoin phospholipasea1memberaactivatesfibroblastlikesynoviocytesthroughtheautotaxinlysophosphatidicacidreceptoraxis